Induction of Capsule Growth inCryptococcus neoformansby Mammalian Serum and CO2
Open Access
- 1 November 2003
- journal article
- Published by American Society for Microbiology in Infection and Immunity
- Vol. 71 (11) , 6155-6164
- https://doi.org/10.1128/iai.71.11.6155-6164.2003
Abstract
The pathogenic fungusCryptococcus neoformanshas a polysaccharide capsule that is essential for virulence in vivo. Capsule size is known to increase during animal infection, and this phenomenon was recently associated with virulence. Although various conditions have been implicated in promoting capsule growth, including CO2concentration, osmolarity, and phenotypic switching, it is difficult to reproduce the capsule enlargement effect in the laboratory. In this study, we report that serum can induce capsule growth, and we describe the conditions that induce this effect, not only by serum but also by CO2. Capsule enlargement was dependent on the medium used, and this determined whether the strain responded to serum or CO2efficiently. Serum was most effective in inducing capsule growth under nutrient-limited conditions. There was considerable variability between strains in their response to either serum or CO2, with some strains requiring both stimuli. Sera from several animal sources were each highly efficient in inducing capsule growth. The cyclic AMP (cAMP) pathway and Ras1 were both necessary for serum-induced capsule growth. The lack of induction in theras1mutant was not complemented by exogenous cAMP, indicating that these pathways act in parallel. However, both cAMP and Ras1 were dispensable for inducing a partial capsule growth by CO2, suggesting that multiple pathways participate in this process. The ability of serum to induce capsule growth suggests a mechanism for the capsular enlargement observed during animal infection.Keywords
This publication has 86 references indexed in Scilit:
- The efficacy of complement‐mediated phagocytosis of Cryptococcus neoformans is dependent on the location of C3 in the polysaccharide capsule and involves both direct and indirectC3‐mediated interactionsEuropean Journal of Immunology, 2003
- Ras1 controls pheromone expression and response during mating in Cryptococcus neoformansFungal Genetics and Biology, 2003
- Adenylyl Cyclase Functions Downstream of the Gα Protein Gpa1 and Controls Mating and Pathogenicity of Cryptococcus neoformansEukaryotic Cell, 2002
- Cryptococcus neoformans var. neoformans (Serotype D) Strains Are More Susceptible to Heat than C. neoformans var. grubii (Serotype A) StrainsJournal of Clinical Microbiology, 2001
- Antibodies Elicited by a Cryptococcus neoformans-Tetanus Toxoid Conjugate Vaccine Have the Same Specificity as Those Elicited in InfectionThe Journal of Infectious Diseases, 1992
- Oral, Topical and Parenteral Antifungal Treatment with Itraconazole in Normal and in Immunocompromised AnimalsMycoses, 1989
- Effect of Hypertonic Solutes Upon the Polysaccharide Capsule in Cryptococcus neoformansMycoses, 1989
- Culture of Cryptococcus neoformans in the nonencapsulated stateMycopathologia, 1981
- The Effect of Mammalian and Avian Sera on the Growth of Cryptococcus Neoformans**From the Mycology Research Laboratory, Division of Medicine, Montefiore Hospital and Medical Center, Bronx, New York, 10467.Journal of Investigative Dermatology, 1967
- VIRULENCE AND GROWTH RATES OF CRYPTOCOCCUS NEOFORMANS IN MICEAnnals of the New York Academy of Sciences, 1960